author-photo

Ricki Englehaupt

Cleveland Clinic

12

Papers

283

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes

2015 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (57)
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease

2014 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (4)
LFA-3/CD2 Pathway, Potential Target For Immunosuppressive Therapy In Aplastic Anemia: A Phase I/II Trial Of Alefacept In Patients With Relapsed/Refractory Aplastic Anemia

2013 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A novel lunar bed rest analogue.

2013 Aviation, Space, and Environmental Medicine
Show All
- Source
- Cite
- Save
Citations (8)
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

2012 Blood
Show All
- Source
- Cite
- Save
Citations (106)
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.

2011 Cancer
Show All
- Source
- Cite
- Save
Citations (28)
Final Results From the Phase 2 Continuation Study of the Lenalidomide and Azacitidine Combination in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

2011 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher‐risk myelodysplastic syndromes

2011 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (48)
Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction Therapy

2010 Blood
Show All
- Source
- Cite
- Save
Citations (4)